BioSpace News Archive

Business

Viking Therapeutics’ NASH Therapy Shows Major Reduction of Liver Fat and LDL Cholesterol

Results of Viking Therapeutics’ metabolic disease program exceed all other oral therapies in development in terms of reducing liver fat for nonalcoholic steatohepatitis (NASH) patients, according to Greg Zante, SVP of finance.

November 19, 2020
·
3 min read
·
Gail Dutton
Career Advice

Productivity Methods That Actually Work

How productive are you on a daily basis? The truth is, you probably don’t get as much done as you possibly can due to distractions. But, these productivity methods can help you for sure.

November 19, 2020
·
3 min read
·
Kymberlie Krieger
AstraZeneca demonstrates strengths in haematology with robust data at ASH 2020

AstraZeneca will present new research aimed at addressing key unmet needs facing patients with blood cancers at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, held virtually from 5 to 8 December 2020.

November 19, 2020
·
10 min read
Drug Development

Research Roundup: Healthcare Workers Highest Risk for COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

November 19, 2020
·
5 min read
·
Mark Terry
Biotech Beach

In Fight Against Blood Cancer, Imago Doubles Down with $80 Million Series C

Funding raised will be used to take lead candidate into Phase III clinical trials.

November 19, 2020
·
2 min read
·
Kate Goodwin
BioCapital

COVID-19 Vaccine Rollout Timeline: Possibly Beginning Distribution in December

The looming question is: when will the public be able to start getting the vaccines?

November 19, 2020
·
5 min read
·
Mark Terry
Business

Sanofi Genzyme’s Bill Sibold Champions Diversity, Community Responsibility

Bill Sibold, executive vice president and head of Sanofi Genzyme, is passionate about fomenting programs that increase the diversity of the workforce in his company and the pharmaceutical industry as a whole.

November 19, 2020
·
3 min read
·
Alex Keown
New Understanding of eTreg Cells Signals Hope for Inflammatory Diseases

Scientists at St. Jude Children’s Research Hospital have revealed insight into the metabolic signaling pathways influencing eTreg cells that could lead to new therapies for inflammatory diseases and related disorders.

November 19, 2020
·
2 min read
·
Heather McKenzie
Business

BioSpace Movers & Shakers, Nov. 20

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

November 19, 2020
·
6 min read
·
Alex Keown
Drug Development

Researchers Create Nasal Spray for COVID-19 That May Already Be Safe for Humans

Researchers from the University of Birmingham, UK, announced today that they have developed a nasal spray that can potentially provide protection against COVID-19. Additionally, it is formulated using materials that have already been cleared for use in humans.

November 19, 2020
·
2 min read
·
Krystle Vermes